Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-11-13

Clinical Trial Update: Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes

View source ↗

Summary

This clinical trial update investigates the effects of Januvia (sitagliptin) on ghrelin and other gut hormones in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Januvia (sitagliptin)

Snippet

Sponsor: Wayne State University | Conditions: Type 2 Diabetes | Status: UNKNOWN